In trading on Wednesday, shares of Capital Power Corp (TSX: CPX.TO) crossed below their 200 day moving average of $54.18, changing hands as low as $54.05 per share. Capital Power Corp shares are ...

Review Capital Power Corp (CPX:XTSE) stock and the current sustainability and ESG risk rating to help with your investing decisions.

Avajar enters Taiwans beauty market with distribution deal at Cosmed and POYA The daily self-care functional cosmetic brand Avajar announced on the 1 ...

Abu Dhabi, UAE – CPX Holding, a leading provider of cutting-edge cyber and physical security solutions and services, will participate at GISEC Global 2025 for the third consecutive year, marking its ...

The UAE Cyber Security Council and CPX, a leading provider of end-to-end cyber and physical security solutions and services, today announced the release of the ‘State of the UAE Cybersecurity ...

During the initial stages of CPX III, the 42 ID encountered a significant challenge in leveraging their MCIS. The main issue was stabilizing the Division tactical network.

Abu Dhabi, UAE – CPX, a leading provider of cutting-edge cyber and physical security solutions and services, today unveiled its strategic expansion plan to accelerate growth, broaden its global ...

At CPX 2025 in Bangkok, Check Point CEO Nadav Zafrir outlined a vision for network security centred on hybrid mesh architecture and AI-powered capabilities.

For example, long term Capital Power Corporation (TSE:CPX) shareholders have enjoyed a 69% share price rise over the last half decade, well in excess of the market return of around 44% (not ...

Canada Cartage, a portfolio company of Mubadala Capital, has agreed to acquire Coastal Pacific Xpress (CPX), a temperature-sensitive transportation and logistic services provider.

Sterilization company Cosmed Group Inc. has filed for bankruptcy protection after being named in lawsuits alleging that its airborne cleaning chemicals caused injuries including cancer.

Liposomal daunorubicin and cytarabine (CPX-351) was effective in relapsed acute myeloid leukemia, but long-term follow-up is needed to determine the extent of the agent's cardiotoxicity.